Collateral for a security interest recorded Mar 10, 2020 (The Director of the Ohio Development Services Agency).
Term ends Mar 10, 2031 · High confidence
20-year base term ends Dec 7, 2029
Held by SPR Therapeutics, Inc.
Filed Dec 7, 2009 as application 12/653,023 · Granted Feb 10, 2015
Base term plus 458 days of patent term adjustment (USPTO delay)
Today
2009
2031
Clock starts
Dec 7, 2009
Dec 7, 2009
Term ends
Mar 10, 2031
Mar 10, 2031
Granted
Feb 10, 2015
Feb 10, 2015
base term
patent term adjustment
fee events
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
458
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
47
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 458 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 7, 2009, when this application, 12/653,023, was filed | Dec 7, 2029 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +458 days, USPTO patent term adjustment record | Mar 10, 2031 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 10, 2031 | High confidence |
Partial family
| US 8,463,383 | In force Jul 2031 | Jul 2031 |
| US 8,954,153 | this patent Mar 2031 | Mar 2031 |
| Application 12/653,029 | Abandoned not computed | not computed |
| Application 13/095,616 | No file history here not computed | not computed |
| US 10,668,285 | In force Dec 2029 | Dec 2029 |
| US 8,788,046 | In force Dec 2029 | Dec 2029 |
| US 8,788,047 | In force Dec 2029 | Dec 2029 |
| US 8,788,048 | In force Dec 2029 | Dec 2029 |
8 of 47 applications in this family shown, earliest filings first. Partial: 2 of the 47 have no file history here, so a row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 22, 2010 Reel 24002, frame 582 | Boggs, II, Joseph W. | Ndi Medical, LLC | Assignment of Assignor's Interest |
| May 30, 2013 Reel 30518, frame 830 | SPR Therapeutics, LLC | The Director of the Ohio Development Services Agency | Security Agreement |
| Sep 24, 2014 Reel 33809, frame 771 | SPR Therapeutics, LLC | Ohio Development Services Agency | Security Interest |
| Nov 9, 2017 Reel 44715, frame 395 | SPR Therapeutics, Inc. | The Director of the Ohio Development Services Agency | Security Interest |
| Dec 6, 2017 Reel 44716, frame 812 | SPR Therapeutics, LLC | SPR Therapeutics, Inc. | Change of Name |
| Oct 15, 2019 Reel 50728, frame 721 | The Director of the Ohio Development Services Agency | SPR Therapeutics, Inc. | Release of Security Interest |
| Mar 10, 2020 Reel 52137, frame 516 | SPR Therapeutics, LLC | The Director of the Ohio Development Services Agency | Corrective Assignment to Correct the the Properties Listed in the Security Interest Previously Recorded at Reel: 030518 Frame: 0830. Assignor(S) Hereby Confirms the Assignment. |
| Jan 30, 2024 Reel 66381, frame 75 | SPR Therapeutics, Inc. | SLR Investment Corp., as Agent | Intellectual Property Security Agreement |
| Jan 30, 2024 Reel 66412, frame 400 | SPR Therapeutics, Inc. | Gemino Healthcare Finance, LLC | Security Interest |
| Feb 8, 2024 Reel 66526, frame 25 | The Director of Development, State of Ohio, Formerly Known as the Director of the Ohio Development Services Agency | SPR Therapeutics, Inc., Formerly Known as SPR Therapeutics, LLC | Release of Security Interest |
| Jul 15, 2026 Reel 75985, frame 374 | Gemino Healthcare Finance, LLC, D/B/A SLR Healthcare ABL | SPR Therapeutics, Inc. | Release of Security Interest |
| Jul 15, 2026 Reel 75985, frame 409 | SLR Investment Corp., as Agent | SPR Therapeutics, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Mar 2031
Term ends Mar 10, 2031. No further fees fall due before then
Note
The 458 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
260
later US patents cite this one
That is top 1% of utility patents granted in 2015 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.